Regulatory/GMP Compliance, Emerging Markets

India's Contract Research and Manufacturing Sector Set for Growth

December 04, 2014

Generic drug manufacturing is no longer the only driver for growth in India's pharmaceutical market as more companies start investing in R&D.

CPhI Releases India Market Report

December 03, 2014

Enhanced R&D efforts and the growing manufacture of finished-dosage drugs in India will shape the country's future success, according to a new report from CPhI.

First Remicade Biosimilar Hits India

December 02, 2014

Ranbaxy and Epirus announce the launch of India's first biosimilar for Remicade.

India—A Force to be Reckoned with in Pharmaceutical Manufacturing

December 02, 2014

Indian manufacturers are moving towards high-value, low-volume work, with complex chemistry and intellectual property challenges.

PTSM: Pharmaceutical Technology Sourcing and Management

Pharma Industry Growth Slows in Brazil

November 01, 2014

The Brazilian economy is being impacted by internal and external factors, and forecast figures are being quickly revised downwards.

Economic Growth Stalls in Brazil

October 02, 2014

Brazil's pharmaceutical industry is optimistic, but is the pharmaceutical market growing steadily or showing signs of instability?

Brand India Pharma Gets Ready for CPhI

September 24, 2014

The campaign supports pharmaceutical growth in India and serves to highlight the value proposition that Indian pharmaceuticals present.

Brazil's Phytotherapic Drug Market and Regulation

July 02, 2014

Is there potential for growth in Brazil's phytotherapic drug market?

PTSM: Pharmaceutical Technology Sourcing and Management

India Offers Biopharma Opportunities and Challenges

May 30, 2014

An established drug-manufacturing base with quality and safety issues, and patent protection and price capping concerns complicate efforts to do business in India.

PTSM: Pharmaceutical Technology Sourcing and Management

Global Instability Impacts Brazil's Pharma Market

May 02, 2014

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?